stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Sab Biotherapeutics IncSABS
$3.120.32%0.01

Sab Biotherapeutics Inc (SABS)

Sab Biotherapeutics Inc Stock (SABS) Financials Data

*All numbers in millions
Period End Date2026-09-302026-06-302026-03-312025-12-312025-09-30
Period Length3 Months3 Months3 Months3 Months3 Months
10.79%25.90
23.3820.0015.7712.68
Research and Development
11.78%18.08
16.1713.4010.738.97
Operating Income/Loss
10.79%-25.90
-23.38-20.00-15.77-12.68
Net Interest Income/Expense
1.61
----
Nonoperating Income/Loss
306.21%3.60
0.891.13-1.0958.12
0.85%-22.30
-22.49-18.87-16.8645.45
Attributable To Parent
0.85%-22.30
-22.49-18.87-16.8645.45
Available To Common Stockholders, Basic
0.85%-22.30
-22.49-18.87-2.855.34
Basic Average Shares
16.91%93.24
79.7553.569.5610.66
Diluted Average Shares
16.91%93.24
79.7553.5631.0477.86
Basic Earnings Per Share
14.29%-0.24
-0.28-0.35-0.510.50
Diluted Earnings Per Share
14.29%-0.24
-0.28-0.35-0.46-0.21
Undistributed Earnings/Loss Allocated To Participating Securities, Basic
-
---14.0240.11

Similar to SABS